HCID 12190565, compound → tert-butyl N-[(3S,7S,8R,9S)-7-benzyl-9-methyl-8-(2-methylallyloxy)-2-oxo-1,5-dioxonan-3-yl]-N-tert-butoxycarbonylcarbamate
Reaction equation
[CH2:1]([C@@H:8]1[C@@H:16]([OH:17])[C@H:15]([CH3:18])[O:14][C:13](=[O:19])[C@@H:12]([N:20]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[C:21](=[O:27])[O:22][C:23]([CH3:26])([CH3:25])[CH3:24])[CH2:11][O:10][CH2:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(=O)(OCC(C)=C)O[C:37]([CH3:40])([CH3:39])[CH3:38]>C1COCC1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.[Fe+2].C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH2:1]([C@@H:8]1[C@@H:16]([O:17][CH2:39][C:37]([CH3:40])=[CH2:38])[C@H:15]([CH3:18])[O:14][C:13](=[O:19])[C@@H:12]([N:20]([C:21]([O:22][C:23]([CH3:26])([CH3:24])[CH3:25])=[O:27])[C:28](=[O:29])[O:30][C:31]([CH3:33])([CH3:32])[CH3:34])[CH2:11][O:10][CH2:9]1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 55 °C
Procedure
To a solution of tert-butyl N-[(3S,7S,8R,9S)-7-benzyl-8-hydroxy-9-methyl-2-oxo-1,5-dioxonan-3-yl]-N-tert-butoxycarbonylcarbamate (3.59 g, 7.49 mmol, 1.00 equiv) in THF (75 ml) was added tert-butyl (2-methylallyl) carbonate (2.58 g, 15.0 mmol, 2.00 equiv). This solution was degassed by placing under vacuum and backfilling with N2 (3×). To this solution were added dppf (0.830 g, 1.50 mmol, 0.200 equiv) and Pd2 dba3 (0.686 g, 0.749 mmol, 0.100 equiv). The resulting dark solution was heated to 55° C. (external temp) for 1 h, and then cooled to room temperature. The solution was concentrated and purified by automated silica gel column chromatography (4-16% acetone in hexanes) to provide tert-butyl N-[(3S,7S,8R,9S)-7-benzyl-9-methyl-8-(2-methylallyloxy)-2-oxo-1,5-dioxonan-3-yl]-N-tert-butoxycarbonylcarbamate (3.68 g, 92%) as a white solid: 1H NMR (400 MHz, CDCl3) δ 7.32-7.22 (m, 2H), 7.22-7.12 (m, 3H), 5.12 (dd, J=8.5, 6.6 Hz, 1H), 5.07-4.98 (m, 1H), 4.98-4.83 (m, 2H), 4.15-4.02 (m, 2H), 3.95 (d, J=11.8 Hz, 1H), 3.86 (dd, J=11.8, 8.5 Hz, 1H), 3.52 (d, J=10.7 Hz, 1H), 3.40 (dd, J=10.9, 6.0 Hz, 1H), 3.23 (t, J=8.8 Hz, 1H), 3.11 (dd, J=13.6, 3.3 Hz, 1H), 2.40 (t, J=12.5 Hz, 1H), 2.01 (d, J=5.6 Hz, 1H), 1.77 (s, 3H), 1.54-1.39 (m, 21H); 13C NMR (101 MHz, CDCl3) δ 169.97, 152.62, 141.78, 140.01, 129.25, 128.33, 126.02, 112.13, 84.93, 83.01, 75.89, 75.20, 70.96, 57.44, 47.00, 35.02, 27.92, 19.79, 18.97; ESIMS (m/z) 556.8 ([M+Na]+).
Workup
- customThis solution was degassed
- temperaturecooled to room temperature
- concentrationThe solution was concentrated
- custompurified by automated silica gel column chromatography (4-16% acetone in hexanes)
Sources & evidence
- ORD record
- ord-2bae8c48d9b440e5af692cf524188531
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08835462B2
Reaction notes
Loading…